Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Conditions
Interventions
Intervention1: 1. Kaba Sura Kudineer Chooranam â?? Decoction â?? Two times daily before 30 min of meals for 7 days
2. Adathodai manapagu â?? 10 ml â??Twice daily with warm water after meals for 7 days
Sponsors
MrsDivyadharshini IAS
Eligibility
Inclusion criteria
Inclusion criteria: S.No Parameter 1. Adult Male/Female subjects above the age of 18 years 2. COVID -19 Positive as determined by RT-PCR 3. Willing to provide written/digital informed consent. 4. COVID - 19 Positive with no clinical signs 5. COVID - 19 Positive with mild symptoms â?? Sneezing, Cough, Sore Throat, Throat Pain, Malaise, Tiredness, Fever, loss of smell, loss of taste 6. COVID - 19 Positive with moderate symptoms â?? Fever with cough, breathlessness but respiratory rate 95% at rest
Exclusion criteria
Exclusion criteria: S. No Parameter 1. Pregnant and Lactating females 2. COVID - 19 Positive with Severe symptoms â?? Respiratory distress ( >24 breath per minute), Oxygen saturation 3. Chronic Renal Failure requiring dialysis (eGFR 4. Known cases of uncontrolled Diabetes ( >9% HbA1c) 5. Known cases of stage 3 Hypertension ( > 160/100 mmHg) 6. Subjects having any medical or surgical condition that would require immediate medical or surgical intervention at the time of screening 7. Subjects having immune compromised status like HIV, Hepatitis, Tuberculosis, Cancer etc. 8. Subjects taking Steroid treatment and or any kind of immunosuppressive therapy 9. Subjects who are participating in any other clinical study or having participated in any other study 1 month prior to screening in the present study. 10. Subjects with bleeding disorders and severe anemia (Hb
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction in Viral load of SARS-CoV-2 at the end of treatment Reduction in clinical symptoms like fever, cough and breathlessness (1. Fever: â?¤36.6°C or -axilla, â?¤37.2 °C oral or â?¤37.8°C rectal or tympanic ; (2. Respiratory rate - â?¤24/minute on room air; (3. Cough - mild or absent on a patient reported scale (cough symptoms score â?¤ 2 points) Timepoint: one week | — |
Secondary
| Measure | Time frame |
|---|---|
| Reduction in incidence of complications Reduction in hospital time Laboratory markers (Laboratory Markers In Covid-19 Patients ) Adverse events/effects Timepoint: one week | — |
Countries
India
Contacts
Public ContactDRASUGANYA
DEPARTMENT OF INDIAN MEDICINE AND HOMEOPATHY
Outcome results
None listed